Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 168

Results For "standard"

1714 News Found

Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx
Digitisation | August 11, 2021

Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx

OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.


Lupin posts net profit of Rs 542.46 cr. in Q1FY22
News | August 11, 2021

Lupin posts net profit of Rs 542.46 cr. in Q1FY22

The profits were bolstered by the Boehringer Ingelheim MEK program income


Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests
Digitisation | August 10, 2021

Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests

Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection


FDA approves Nexviazyme for late-onset Pompe disease
Drug Approval | August 09, 2021

FDA approves Nexviazyme for late-onset Pompe disease

Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells


Union Minister Sonowal promises AIIA of establishing a Bio-bank in Ayurveda
Events | August 09, 2021

Union Minister Sonowal promises AIIA of establishing a Bio-bank in Ayurveda

All India Institute of Ayurveda hosts ministers and showcase their achievements


We plan to invest Rs. 1,000 Cr in the next 3 to 4 years : Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals
interviews | August 07, 2021

We plan to invest Rs. 1,000 Cr in the next 3 to 4 years : Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals

India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.


Govt augments PSEs and Bharat Biotech to ramp up Covaxin production
Policy | August 06, 2021

Govt augments PSEs and Bharat Biotech to ramp up Covaxin production

CDSCO to fast-track trials and approval for COVID19 vaccine


India’s gets its first bio-bank for heart failure research
Drug Approval | August 06, 2021

India’s gets its first bio-bank for heart failure research

Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology


Covaxin receives approval from Hungary
Biotech | August 05, 2021

Covaxin receives approval from Hungary

More countries recognise Covaxin


Biotech-PRIDE guidelines released
Biotech | August 05, 2021

Biotech-PRIDE guidelines released

Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.